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Nothing is known about the possible effect of thymol or other compounds of essential oils against the adult worms of cestodes.The
aim of the present work was to determine in vitro cestodicidal activity of thymol againstMesocestoides corti adult worms. Moreover,
the in vitro effect on tetrathyridia was also demonstrated. Tetrathyridia exposed to different concentrations of thymol showed
a concentration and time-dependent effect. At lower concentrations, the main change observed was mainly in morphology, with
larvae exhibiting an elongation of the body.When tetrathyridia were exposed to higher concentrations, increased surface alterations
and damage were detected. The body appeared elongated and flattened, and a complete loss of morphology and microtriches was
observed. Thymol was able to killM. corti tetrathyridia, since following inoculation of treated parasites in mice no parasites could
be recovered.The effect onM. corti adult wormswas dose and time-dependent. Changes inmotility coincide with the tissue damage
were observed at the structural and ultrastructural level. Thymol caused severe damages to both developmental stages analyzed.
Damages were more significant in fully segmented worms. The data reported in this paper demonstrate a clear in vitro effect of
thymol againstM. corti tetrathyridia and adult worms.
1. Introduction
Helminth parasitism remains an underappreciated scourge
for humans in most of the developing world. As many as two
billion individuals harbor these parasites, all of which often
result in chronic debilitatingmorbidity [1]. Despite this, there
are still several unresolved issues in anthelmintic pharmacol-
ogy for helminthiases of humans. After decades of clinical
experience with anthelmintics for the treatment of human
infections, most currently used drugs have very poor cestoci-
dal activity. Furthermore, there is a general lack of knowledge
about anthelmintic effects upon different developmental
stages of cestode parasites, especially due to difficulties in
dealing with sexually maturing stages from species infective
to humans [2].
Mesocestoides corti tetrathyridia have been commonly
used for the evaluation of anthelmintic effects [2], but the
establishment of an inducible in vitro strobilation system [3]
now allowed the study of the differential drug susceptibil-
ity of distinct developmental forms. A reduced number of
compounds have been investigated, using in vitro cultured
parasites and/or applying in vivo rodent models. Tested
compounds against tetrathyridia include anti-infective agents
like praziquantel and albendazole [4–7]. On the other hand,
the effects of praziquantel and albendazole were also evalu-
ated against the adult forms [2].
The control of helminthiases and, generally, of all parasitic
diseases is usually made with synthetic anthelmintics. The
appearance of resistance stimulated the research of alterna-
tives, such asmedicinal plants [8].Many drugs originate from
herbal sources: a century ago,most of the effective drugs were
plant based.The development of drugs fromplants continues,
with drug companies engaged in pharmacological screening
of herbs [9].Thepharmaceutical properties of aromatic plants
are partially attributed to essential oils. To date, essential
oils are presented as valuable therapeutic options against
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a number of diseases [10]. Moreover, several essential oils and
their constituents have been found to possess anthelmintic
activity [11, 12].
Recent studies demonstrating the in vitro efficacy of sev-
eral essential oils against Echinococcus granulosus protoscole-
ces implied that these substances and/or their main com-
pounds could also be promising sources of new drugs and
may lead to the improvement of natural therapeutic options
for the human treatment of cystic echinococcosis [13–15].The
in vitro protoscolicidal effect of thymol was demonstrated
[13].Moreover, the in vitro and in vivo effect of thymol against
hydatid cysts was observed (unpublished data). Nevertheless,
nothing is known about the possible effect of thymol or other
compounds of essential oils against the adult worms.
Thymol is one of the major components of the essential
oils of Thymus spp. and is a widely known antimicrobial
agent. From the analysis of this chemical structure, it could be
inferred that, fromabiophysical point of view, this compound
would have an amphipathic and/or a hydrophobic behavior.
This suggests an ability of thymol to partition in the mem-
brane from an aqueous phase as well as a capacity to affect
the membrane organization and the surface electrostatics.
This assumption may explain the effects of thymol on the
permeability of membranes and on the activity of membrane
intrinsic proteins such as ATPases or membrane receptors
[16].
The aim of the present work was to determine in vitro ces-
todicidal activity of thymol against Mesocestoides corti adult
worms. Moreover, the in vitro effect on tetrathyridia was also
demonstrated.
2. Materials and Methods
2.1. Experimental Animals and Source of Parasites. Animal
procedures and management protocols were carried out in
accordance with the 2011 revised form of the Guide for the
Care and Use of Laboratory Animals published by the U.S.
National Institutes of Health. Unnecessary animal suffering
was avoided throughout the study. Tetrathyridia initially
provided by Dr. Henrique Ferreira (Universidade Federal
do Rio Grande do Sul, Brazil) were maintained by serial
passages in females of both CF-1 mice and Wistar rats.
The animals were inoculated by intraperitoneal injection of
200mL of larvae (approximately 500 tetrathyridia) in mice
and 500mL of larvae (approximately 1,200 tetrathyridia) in
rats, suspended in RPMI 1640mediummodifiedwithHEPES
(Emeve Media, 2.05mM L-glutamine and 25mM HEPES).
After a period of 3–5months, larvae were harvested from rats
and transferred to mice as described by Markoski et al. [3].
2.2. Collection of Tetrathyridia. After 3–5 months, the inoc-
ulated experimental hosts were euthanized, necropsy was
carried out immediately thereafter, and larvae were collected.
Yields per infected animal in volumes of 1–9mL for mice and
1-2mL for rats were obtained. After harvesting, tetrathyridia
were washed 6 times in PBS (with addition of 100𝜇g/mL
streptomycin, 60𝜇g/mL penicillin, and 50 𝜇g/mL gentam-
icin) and stored at 4∘C in the same antibiotic-added medium
for a maximum of 48 hours.
2.3. Drug Treatment on Tetrathyridia. Tetrathyridia of M.
corti were isolated under aseptic conditions from CF-1 mice.
Tetrathyridia were cultured in RMPI 1640 medium, supple-
mented with 100 𝜇g/mL streptomycin, 60 𝜇g/mL penicillin,
and 50 𝜇g/mL gentamicin. Cultures were performed on 24
well plates (20𝜇L of tetrathyridia per well), supplied with
3mL/well of RPMI 1640 medium, and incubated at 37∘C.
Thymol (Sigma)was dissolved in dimethyl sulfoxide (DMSO)
at a drug concentration of 100mg/mL and added to the
medium resulting in final concentrations of 250, 200, 150, 100,
50, 25, and 10 𝜇g/mL. Tetrathyridia incubated with culture
medium alone and with culture medium containing DMSO
were used as controls. Exposure to each drug concentration
was carried out in quadruplicate. Samples of tetrathyridia for
scanning electronmicroscopy (SEM) were taken after 1 h and
18–20 h (overnight) following incubation.
2.4. Determination of Infectivity to Mice. Tetrathyridia (500
per Leighton tube) were cultured in RPMI 1640 medium,
containing 60 𝜇g/mL penicillin, 100 𝜇g/mL streptomycin,
and 50 𝜇g/mL gentamicin. Cultures were performed in 10mL
of incubation medium at 37∘C. Thymol was added to the
medium resulting in a final concentration of 250𝜇g/mL.
Tetrathyridia incubated with culture medium containing
DMSO were used as controls. Parasites were recovered after
18–20 h (overnight incubation), washed, and used to infect
8 mice by intraperitoneal inoculation (200 𝜇L of larvae per
animal, 4 control and 4 treated mice). Animals were housed
in a temperature-controlled (22∘C ± 1∘C), light-cycled (12 h
light/dark cycle) room. Food and water were provided ad
libitum. After 2 months following infection, mice were euth-
anized and parasites were recovered from their peritoneal
cavity. The efficacy of chemotherapy was estimated through
the percentage: (mean from control group-mean from treated
group)/mean from control group × 100 (wheremean refers to
the volume of recovered parasites).
2.5. Segmentation Induction. Tetrathyridia segmentation was
induced as previously described by Markoski et al. [3].
Briefly, starved cultured larvae were incubated in RPMI 1640
medium containing 0.662% (w/v) trypsin (Gibco) during
24 hours. After induction, cultures were transferred to 24
well plates (20𝜇L of tetrathyridia per well), supplied with
3mL/well of RPMI 1640 medium, supplemented with 20%
fetal bovine serum (Gibco), and maintained at 39∘C for up to
10–12 days. The medium was changed every 2 days to avoid
excessive acidification.
2.6. Drug Treatment on Adult Worms. Cultured worms, after
strobilation induction at 12 days, were submitted to thymol
treatment. Cultures were performed on 24 well plates (20𝜇L
of parasites per well), supplied with 3mL/well of RPMI 1640
medium, and incubated at 37∘C without changes of medium.
Thymol was dissolved in DMSO and added to the medium
resulting in final concentrations of 250, 200, and 150 𝜇L/mL.
Worms incubated with culture medium containing DMSO
were used as controls. Exposure to each drug concentra-
tion was carried out in quadruplicate. Culture plates were
observed microscopically during the first hour and changes
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were photographed. Samples of tetrathyridia for SEM were
taken after 15, 30, and 60min and 18–20 h (overnight) fol-
lowing incubation.
2.7. Scanning Electron Microscope. Samples of tetrathyridia
and adult worms were processed for SEM as described by
Elissondo et al. [17] for E. granulosus samples. The fixation
time was modified. Briefly, samples were fixed with 3%
glutaraldehyde in sodium cacodylate buffer for 48 h at 4∘C.
Then several washes in cacodylate buffer were made and
the specimens were dehydrated by sequential incubations
in increasing concentrations of ethanol (50–100%) and were
finally immersed in hexamethyldisilazane for 5min, 1 h, and
then overnight. They were then sputter-coated with gold
(100 A˚ thick) and inspected on a JEOL JSM-6460 LV scanning
electron microscope operating at 15 kV.
3. Results
3.1. Drug Treatment on Tetrathyridia. Control tetrathyridia
incubated in RPMI medium or in RPMI + DMSO medium
remained unaltered, and no changes in ultrastructure were
observed (Figure 1(a)).Themain change observed after expo-
sure of tetrathyridia to 100, 50, 25, and 10 𝜇g/mL of thymol
was mainly in morphology, with larvae exhibiting an elon-
gation of the body (Figure 1(b)). Additionally, the presence
of blebs and holes or depressions could be observed (Figures
1(c) and 1(d)). Microtriches remained unaltered after 18–20 h
(overnight) of incubation. Increasing the concentration of
the drug did not result in a proportional increase in the
observable damage.
On the other hand, when tetrathyridia were exposed to
250, 200, and 150 𝜇g/mL of thymol, there were increased sur-
face alterations and damage to the larvae. Tetrathyridia lost
their microtriches, the tegument was markedly altered, and
the body appeared elongated and flattened (Figures 1(e)–
1(g)). Moreover, a decrease in activity was observed. After
overnight exposure, complete loss of morphology and paral-
ysis were observed (Figure 1(h)).
3.2. Infectivity toMice. Micewere infectedwithM. corti tetra-
thyridia that had been exposed to thymol (250 𝜇g/mL) for
18–20 h. Control mice were inoculated with untreated tetra-
thyridia. SEM studies, realized before the infection, demon-
strated the unaltered structure of control larvae and the
drug-induced ultrastructural damage on treated parasites
(Figures 2(a) and 2(c)). After 2 months following infection,
mice were necropsied and larvae were collected. The volume
of parasites recovered from control animals was 1.68mL.
SEM demonstrated the unaltered appearance of tetrathyridia
(Figure 2(b)). On the other hand, no larvae were found in
mice infected with thymol-treated tetrathyridia. The efficacy
of chemotherapy was 100%.The results from this trial proved
the lack of viability of tetrathyridia exposed to thymol
(250𝜇g/mL, overnight), since all of larvae failed to survive
following their inoculation into mice.
3.3. Drug Treatment on Adult Worms. No changes in struc-
ture or ultrastructure were observed on control worms
throughout the experimental period (Figures 3(a) and 4(a)).
Moreover, the motility was not affected with the presence of
the usual contraction movements of the body. Following a
short incubation time (2–5min) at the studied concentrations
of thymol, a decrease in activity of the parasites was observed.
After 30min, a complete paralysis was noted with the higher
concentrations of drug (200 and 250𝜇g/mL). At 150 𝜇g/mL,
complete paralysis was detected after 2 h following incuba-
tion.
Changes in motility coincide with the tissue damage
observed at the structural and ultrastructural levels. The
primary site of damagewas the tegument of the parasite. After
10min following incubation at 250 and 200𝜇g/mL, tegu-
mental alterations could be observed by inverted microscope
alongside debris of tegument in the culture medium (Fig-
ure 3(b)). The surface of the body was extensively damaged
and the presence of blebs was evident. Some worms showed
damage to the posterior part of the body, which probably
resulted in a total disruption of the tegumental layers and
an influx of culture medium into the worm (Figure 3(c)).
The same lesions in the tegument were detected after 30min
following incubation at 150 𝜇g/mL (Figure 3(d)).
Studies by SEM revealed that ultrastructural damage was
produced in thymol-treated worms. After 15min following
incubation, marked tegumental alterations and the complete
loss of microtriches were detected at 200 and 250 𝜇g/mL
(Figure 4(b)). When segmented forms were incubated with
the same concentrations of thymol for 1 h, more pronounced
changes, such as loss or morphology and extensive erosion
of the tegument, were induced (Figure 4(c)). Moreover, the
constrictions between proglottids became difficult to distin-
guish or differentiate (Figure 4(d)). These specimens were
considered to be dead. As it was mentioned for optical
observations, at 150 𝜇g/mL changes produced by the drug
treatment were detected later. After 1 h following incubation
tegumental damage and partial loss of microtriches were
observed (Figure 4(e)). After overnight incubation, worms
were totally altered, with complete loss of morphology (Fig-
ure 4(f)).
4. Discussion
Development of new efficient drugs for the treatment of
human and animal infections caused by cestodes is an urgent
issue for pharmacologists. Over the past ten years, the main
research goal in our laboratory has been the experimental
chemotherapy of cystic echinococcosis. We evaluated the in
vitro and in vivo anthelmintic effects of different synthetic and
natural drugs [13–15, 17–20].
As opposed to larval stage of E. granulosus, the infection
in the definitive host has not been so widely studied and
comparatively fewer experimental data have been gathered
[21]. Up to now research on in vitro cultures of adults has
proven difficult, only reaching some degree of maturation in
the diphasicmedium [22]. For this reason, we thought thatM.
corti adult worms could be an interesting in vitro model for
the screening of new drugs against canine echinococcosis.
No previous publications were found about the anthel-
mintic in vitro effect of thymol on cultured M. corti
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(a) (b)
(c) (d)
(e) (f)
(g) (h)
Figure 1: Scanning electron microscopy of Mesocestoides corti tetrathyridia incubated in vitro with thymol. (a) Control tetrathyridium
(70x). (b) Altered tetrathyridium after 1 h following incubation (100 𝜇g/mL). Note the elongation of the body (37x). (c) Thymol-treated
tetrathyridium. Observe the blebs and depressions (1 h, 25 𝜇g/mL, 150x). (d) Detail of blebs and depressions (1 h, 25𝜇g/mL, 150x). (e)
Alterations in the tegument of the suckers region (1 h, 150 𝜇g/mL, 300x). (f) Larvae showing the surface damage produced by thymol
(1 h, 200 𝜇g/mL, 65x). (g) Altered tetrathyridium (1 h, 250𝜇g/mL, 65x). The body appeared elongated and flattened. (h) Completely altered
tetrathyridium after overnight incubation (250𝜇g/mL, 95x).
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(a) (b)
(c)
Figure 2: Determination of infectivity tomice. (a) Control tetrathyridium before being injected intomouse (85x). (b) Control tetrathyridium
extracted from amouse after 2months following infection (100x). (c) Tetrathyridium exposed to thymol (250 𝜇L/mL, overnight) before being
injected into mouse. Note the loss of morphology and microtriches. The body appeared elongated and flattened (50x).
(a) (b)
(c) (d)
Figure 3: Inverted optical microscope of Mesocestoides corti adult worms incubated in vitro with thymol. (a) Control adult worm (100x).
Partial view of a strobila. (b) Altered adult worm after 10min of incubation with thymol (250 𝜇g/mL). The tegument is altered and debris
of tegument could be observed in the culture medium (100x). (c) Adult worm (10min, 200 𝜇g/mL). Note the tegumental damage and the
influx of culture medium into the worm (100x). (d) Adult worms after 30min of incubation with thymol (150𝜇g/mL). Note the tegumental
alterations with the presence of blebs and loss of morphology (100x).
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(a) (b)
(c) (d)
(e) (f)
Figure 4: Scanning electron microscopy of Mesocestoides corti adult worms incubated in vitro with thymol. (a) Control adult worm (43x).
(b) Adult worm after 15min of incubation (250 𝜇g/mL). Note the tegumental alterations (75x). (c) Partial view of a strobila. Observe the
extensive erosion of the tegument (1 h, 200 𝜇g/mL, 200x). (d) Altered adult worm (1 h, 250𝜇g/mL). The constrictions between proglottids
became difficult to distinguish (80x). (e) Adult worm after 1 h following incubation. Partial loss of microtriches (1 h, 150𝜇g/mL, 100x). (f)
Adult worm totally altered after overnight incubation (150𝜇g/mL, 60x).
tetrathyridia and adult worms. Besides, this work is the first
report of the effect of a component of essential oils on this
parasite.
Tetrathyridia exposed to different concentrations of thy-
mol showed a concentration and time-dependent effect
involving morphological damage. The employment of SEM
allowed us to examine, at an ultrastructural level, the effects
induced by thymol onM. corti tetrathyridia.Themain change
observed after exposure was mainly in morphology, with
larvae exhibiting an elongation of the body. Additionally, the
presence of blebs and holes or depressions could be observed.
At lower concentrations, microtriches remained unaltered.
Increasing the concentration from 10 to 100 𝜇g/mL did not
result in a proportional increase in the observable damage.
When tetrathyridia were exposed to 250, 200, and 150 𝜇g/mL
of thymol, there were increased surface alterations and dam-
age to the larvae.The body appeared elongated and flattened,
and a complete loss of morphology and microtriches was
observed. The alteration of microtriches probably interferes
with tetrathyridia nutrition since microtriches are directly
associated with the nutrients absorption. These ultrastruc-
tural changes have also been observed on tetrathyridia
cultured in the presence of free and liposomized praziquantel
[5]. Furthermore, Hrcˇkova´ et al. [5] observed an increase in
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motility of tetrathyridia. In contrast, a decrease in activity and
paralysis was observed when larvae were incubated with thy-
mol. Moreover, as evidenced in our experiments, thymol was
able to killM. corti tetrathyridia, since following inoculation
of treated parasites in mice no parasites could be recovered
after two months following inoculation in all mice infected
with thymol-treated parasites.
On the other hand, the efficacy of thymol was also
demonstrated in vitro on M. corti adult worms. As occurred
for tetrathyridia, the effect was dose and time dependent. A
correlation between the intensity of damage and the concen-
tration of thymol was observed. Our results are consistent
with those reported by Chavasse et al. [23], where adult Schis-
tosoma mansoni, incubated with praziquantel, showed a
decrease in activity and paralysis. Changes in motility coin-
cide with the tissue damage observed at the structural and
ultrastructural levels. The primary site of damage was the
tegument of the parasite. SEM studies revealed that, even after
a short incubation time, marked tegumental alterations and
the complete loss of microtriches were detected.
Thymol caused severe damage to the two developmental
stages analyzed. However, damage was more significant in
fully segmented worms. This difference was also observed
by Markoski et al. [2] working with praziquantel and alben-
dazole. They stated that the observed effects are probably
representative of those happening to intestine living adult
cestode worms upon host oral treatment with these drugs.
We consider that a possible limitation of this study is the
lack of in vivo studies. Moreover, exhaustive evaluation of
thymol chemotherapeutic efficiency in vitro on tetrathyridia
and adult worms should be undertaken.
In conclusion, the data obtained clearly demonstrated
that the in vitro treatment with thymol is effective againstM.
corti tetrathyridia and adult worms. The results obtained on
tetrathyridia are consistent with our previous observations
working in vitro with E. granulosus larval forms [13]. As far
as we know, this is the first time that the anthelmintic effect
of a compound of a phytotherapic drug upon adult worms of
cestodes is assessed. In the next step, we will investigate the
in vitro and in vivo efficacy of thymol against E. granulosus
adults.
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